Biodexa Pharmaceuticals Plc (BDRX) stock
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.24−0.16 (-6.67%)
Close on Nov 16, 2026Market cap $5.06MP/E –Yield –
Biodexa Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Biodexa Pharmaceuticals's total assets was £12.72M at Jun 30, 2026. For fiscal 2025 it was £18.18M, up 23.0% from the year before. Over ten years it grew -11.8% a year on average. The highest annual figure on record is £64.04M in fiscal 2015.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | £18.18M | +23.0% |
| FY2024 | Dec 31, 2024 | £14.78M | +40.2% |
| FY2023 | Dec 31, 2023 | £10.54M | +90.8% |
| FY2022 | Dec 31, 2022 | £5.53M | -57.2% |
| FY2021 | Dec 31, 2021 | £12.91M | +31.5% |
| FY2020 | Dec 31, 2020 | £9.82M | -68.2% |
| FY2019 | Dec 31, 2019 | £30.90M | +51.1% |
| FY2018 | Dec 31, 2018 | £20.44M | -58.5% |
| FY2017 | Dec 31, 2017 | £49.22M | -13.2% |
| FY2016 | Dec 31, 2016 | £56.69M | -11.5% |
| FY2015 | Dec 31, 2015 | £64.04M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | £12.72M | -8.9% |
| Q4 FY2025 | Dec 31, 2025 | £18.18M | +72.4% |
| Q2 FY2025 | Jun 30, 2025 | £14.82M | +86.2% |
| Q4 FY2024 | Dec 31, 2024 | £14.78M | +167.5% |
| Q2 FY2024 | Jun 30, 2024 | £13.97M | +8.2% |
| Q4 FY2023 | Dec 31, 2023 | £10.54M | +7.4% |
| Q2 FY2023 | Jun 30, 2023 | £7.96M | -74.2% |
| Q4 FY2022 | Dec 31, 2022 | £5.53M | -73.0% |
| Q4 FY2021 | Dec 31, 2021 | £12.91M | -73.8% |
| Q4 FY2020 | Dec 31, 2020 | £9.82M | -82.7% |
| Q4 FY2019 | Dec 31, 2019 | £30.90M | -51.8% |
| Q4 FY2018 | Dec 31, 2018 | £20.44M | – |
| Q4 FY2017 | Dec 31, 2017 | £49.22M | – |
| Q4 FY2016 | Dec 31, 2016 | £56.69M | – |
| Q4 FY2015 | Dec 31, 2015 | £64.04M | – |
See a number that looks wrong?